Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> SANOFI Latest News

NOV 20, 2014 - Yahoo! News

A Must Read - Share

Sanofi touts new drugs but diabetes outlook disappoints

By Natalie Huet PARIS (Reuters) - Sanofi, which sacked its chief executive three weeks ago, gave a weak sales outlook for its diabetes drugs on Thursday, overshadowing plans to reap more than 30 billion euros ($38 billion) from new medicines. The French drugmaker said it aimed to launch up to 18 new drugs by the end of 2020 and told ...

Tags: Sanofi touts new drugs but diabetes outlook disappoints,  Sanofi Latest News

NOV 17, 2014 - Wall Street Journal

A Must Read - Share

MS Drug Gets FDA Approval

Sanofi said its U.S. subsidiary Genzyme has received approval from the Food and Drug Administration for its multiple-sclerosis drug Lemtrada.

Tags: MS Drug Gets FDA Approval,  Sanofi Latest News

NOV 15, 2014 - Reuters

A Must Read - Share

U.S. FDA approves Sanofi's MS drug Lemtrada

PARIS (Reuters) - The U.S. Food and Drug Administration has approved Sanofi's multiple sclerosis treatment Lemtrada, Sanofi said in a statement on Saturday.

Tags: U.S. FDA approves Sanofi's MS drug Lemtrada,  Sanofi Latest News

NOV 13, 2014 - Yahoo! News

A Must Read - Share

Wearable injectors march into healthcare

Wearable trackers are so 2014: The next big thing could be wearable injectors, as delivery device maker Unilife signs a deal with drug maker Sanofi that could mean they'll soon be coming in large numbers to a pharmacy near you.

Tags: Wearable injectors march into healthcare,  Sanofi Latest News

NOV 11, 2014 - Yahoo! News

A Must Read - Share

Sanofi's dual-action biotech asthma drug performs well in test

(Reuters) - An experimental biotech drug for moderate to severe asthma from France's Sanofi and its U.S. partner Regeneron has produced good results in clinical tests, suggesting that its dual-action mechanism may be highly effective. The encouraging data allows the companies to begin final-stage Phase III asthma trials on the medicine, which is also being developed for atopic dermatitis and ...

Tags: Sanofi's dual-action biotech asthma drug performs well in test,  Sanofi Latest News